Pharming Group

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Pharming Group and other ETFs, options, and stocks.

About PHAR

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema.

CEO

Fabrice Chouraqui

CEOFabrice Chouraqui

Employees

—

Employees—

Headquarters

Leiden, Zuid-Holland

HeadquartersLeiden, Zuid-Holland

Founded

1988

Founded1988

Employees

—

Employees—

PHAR Key Statistics

Market cap

702.52M

Market cap702.52M

Price-Earnings ratio

-52.74

Price-Earnings ratio-52.74

Dividend yield

—

Dividend yield—

Average volume

2.87K

Average volume2.87K

High today

$10.34

High today$10.34

Low today

$10.24

Low today$10.24

Open price

$10.27

Open price$10.27

Volume

4.01K

Volume4.01K

52 Week high

$12.61

52 Week high$12.61

52 Week low

$6.65

52 Week low$6.65

Pharming Group

Why Robinhood?

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. Show more

PHAR Key Statistics

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema.